Complete remission with ibrutinib after allogeneic stem cell transplant for central nervous system relapse of mantle cell lymphoma: A case report and literature review

Central nervous system (CNS)‐relapsed mantle cell lymphoma (MCL) is a rare, aggressive non‐Hodgkin lymphoma without a standard treatment. Ibrutinib has shown promising results for inducing remission in other non‐Hodgkin lymphomas and may be considered as successful treatment for CNS‐relapsed MCL in...

Descripción completa

Detalles Bibliográficos
Autores principales: Rich, Jessica D., Clark, Stephen M., Fedoriw, Yuri, Jewells, Valerie, Wood, William, Dittus, Christopher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6787781/
https://www.ncbi.nlm.nih.gov/pubmed/31624617
http://dx.doi.org/10.1002/ccr3.2257

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6787781/
https://www.ncbi.nlm.nih.gov/pubmed/31624617
http://dx.doi.org/10.1002/ccr3.2257

Ejemplares similares